Skip to content

Clinical Research on the Efficacy of Syndrome Differentiation and Rehabilitation Treatment for Neurogenic Bladder Urinary Retention after Spinal Cord Injury with Traditional Chinese Medicine

Research on the Clinical Protocol of Syndrome Differentiation and Rehabilitation Treatment of Traditional Chinese Medicine for Neurogenic Bladder Urinary Retention after Spinal Cord Injury

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001156
Enrollment
Unknown
Registered
2025-06-12
Start date
2024-01-01
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

spinal cord injury

Interventions

experimental group:Conventional rehabilitation therapy + comprehensive traditional Chinese medicine rehabilitation therapy
control group:Conventional rehabilitation therapy

Sponsors

Henan Provincial Hospital of Traditional Chinese Medicine (The Second Affiliated Hospital of Henan University of Chinese Medicine)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria: 1.Diagnosis of neurogenic bladder with urinary retention following spinal cord injury; 2.Duration of spinal cord injury 100ml; 5.Age between 18 and 70 years (inclusive) regardless of gender; 6.Voluntary participation in the trial with signed informed consent from either the patient or their legal guardian.

Exclusion criteria

Exclusion criteria: (1) Patients with serious diseases of important organs such as the heart brain and kidneys; (2) Patients with abnormal urination caused by reasons such as mechanical obstruction at the urethral meatus; (3) Patients with severe autonomic hyperreflexia during urination; (4) Patients who have undergone surgical treatments such as cystostomy anterior urethral sphincterotomy artificial urethral sphincter implantation and sacral nerve and spinal cord stimulation device implantation; (5) Patients with serious infections during the examination or with bladder muscle injury; (6) Patients who are currently participating in other clinical trials that may affect the evaluation of the results of this study.

Design outcomes

Primary

MeasureTime frame
voluntary urine output;Residual urine volume in the bladder;

Secondary

MeasureTime frame
Bladder safe pressure;The number of subjects with urinary tract infections;Number of subjects with established balanced bladder;Maximum bladder capacity;Number of subjects with restored spontaneous urination;Urine flow rate;Maximum bladder pressure;Urinary incontinence condition;Quality of life of patients;recurrence rate;safe bladder capacity;

Countries

The People's Republic of China

Contacts

Public Contactliyanjie

Henan Provincial Hospital of Traditional Chinese Medicine (The Second Affiliated Hospital of Henan University of Chinese Medicine)

232410974@qq.com15838264302

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026